| Recruiting | A Study of ASP546C in Adults With Gastroesophageal Cancer, Pancreatic Cancer or Other Solid Tumors Gastric or Gastro-esophageal Junction (GEJ) Adenocarcinoma, Pancreatic Adenocarcinoma | Phase 1 / Phase 2 | 2026-03-20 |
| Recruiting | A Study to Find Out if Enfortumab Vedotin Given With Pembrolizumab Helps People With Muscle-invasive Bladder C Muscle-invasive Bladder Cancer | Phase 2 | 2026-03-12 |
| Recruiting | A Study to Learn How Stargardt-type Eye Conditions Progress in Children and Adults Stargardt Disease, Stargardt Macular Dystrophy, Stargardt-like Macular Dystrophy | — | 2026-02-20 |
| Recruiting | A Study to Evaluate the Effectiveness and Safety of Setidegrasib, Given With Either mFOLFIRINOX or NALIRIFOX C Pancreatic Cancer, Metastatic Pancreatic Cancer, Metastatic Pancreatic Adenocarcinoma | Phase 3 | 2026-02-17 |
| Recruiting | A Study of ASP2998 Given by Itself and Given With Standard Therapies in People With Solid Tumors Locally Advanced or Metastatic Malignant Solid Tumors | Phase 1 / Phase 2 | 2026-02-05 |
| Recruiting | A Study to Learn How Fluconazole, Carbamazepine and Itraconazole Affect How the Body Processes ASP3082 in Heal Healthy Volunteer | Phase 1 | 2026-02-03 |
| Recruiting | A Study to Evaluate the Safety and Drug Levels of ASP5541 in Chinese Participants With Prostate Cancer Prostate Cancer, Metastatic Castration-Resistant Prostate Cancer, Metastatic Hormone Sensitive Prostate Cancer | Phase 1 | 2026-01-20 |
| Recruiting | A Study of ASP2138 Given Before Surgery, Then Chemotherapy After Surgery, in People With Pancreatic Ductal Can Pancreatic Ductal Adenocarcinoma | Phase 1 | 2025-10-16 |
| Active Not Recruiting | A Study of Zolbetuximab With Chemotherapy in Adults With Pancreatic Cancer Metastatic Pancreatic Adenocarcinoma | Phase 1 | 2025-09-24 |
| Recruiting | A Study of Gilteritinib in Adults With Advanced ALK-positive Non-small Cell Lung Cancer (NSCLC) Non-small Cell Lung Cancer (NSCLC), Anaplastic Lymphoma Kinase (ALK) Positive | Phase 1 | 2025-09-22 |
| Recruiting | A Safety Study of Enfortumab Vedotin in Indian Adults With Urothelial Cancer Metastatic Urothelial Carcinoma | Phase 4 | 2025-06-21 |
| Recruiting | A Phase 2 Study to Evaluate the Effects of ASP5541 in Participants With Prostate Cancer Prostate Cancer, Metastatic Castration-Resistant Prostate Cancer, Metastatic Hormone Sensitive Prostate Cancer | Phase 2 | 2025-06-19 |
| Recruiting | A Study of Zolbetuximab Together With Pembrolizumab and Chemotherapy in Adults With Gastric Cancer Locally Advanced Unresectable Gastroesophageal Junction (GEJ) Adenocarcinoma or Cancer, Locally Advanced Unresectable Gastric Adenocarcinoma or Cancer, Metastatic Gastric Adenocarcinoma or Cancer | Phase 3 | 2025-05-22 |
| Completed | A Study to Confirm if Fezolinetant Helps Reduce Hot Flashes in Chinese Women Going Through Menopause Hot Flashes | Phase 2 | 2025-03-10 |
| Recruiting | A Study to Learn How Avacincaptad Pegol (Izervay™) is Used in Clinical Practice in People Who Have Geographic Geographic Atrophy, Macular Degeneration | — | 2025-01-22 |
| Withdrawn | A Study of ASP1893 in Adults With Advanced CLDN6-positive Solid Tumors CLDN6-positive Solid Tumor, Ovarian Cancer, Endometrial Cancer | Phase 1 | 2024-12-31 |
| Completed | Experiment to Assess Preferences for Novel Hormonal Therapy and Androgen-deprivation Therapy in Prostate Cance Prostate Cancer | — | 2024-11-22 |
| Terminated | A Study to Find a Suitable Dose of ASP2802 in People With CD20-positive B-cell Lymphomas B-cell Lymphoma | Phase 1 | 2024-09-06 |
| Terminated | A Study to Evaluate the Effects of ASP5502 in Healthy Adults and Adults With Primary Sjögren's Syndrome Healthy Volunteers, Sjögren's Syndrome | Phase 1 | 2024-08-21 |
| Active Not Recruiting | A Study to Confirm if Fezolinetant Helps Reduce Hot Flashes in Women With Breast Cancer Who Are Having Hormone Hot Flashes | Phase 3 | 2024-07-31 |
| Terminated | A Study of ASP1012 in Adults With Solid Tumors Solid Tumor | Phase 1 | 2024-05-15 |
| Completed | A Study to Find Out if ASP5354 Can Clearly Help Show the Ureter During Surgery in People With or Without Kidne Intraoperative Ureter Visualization, Abdominolpelvic Surgery | Phase 3 | 2024-03-19 |
| Active Not Recruiting | A Study to Learn How Effective and Safe the Drug 'Mirabegron' is and How Long it Stays in the Body of Children Neurogenic Detrusor Overactivity | Phase 3 | 2024-02-28 |
| Recruiting | A Study of Roxadustat to Treat Anemia in Children and Teenagers With Chronic Kidney Disease Chronic Kidney Disease, Renal Anemia | Phase 3 | 2024-01-16 |
| Active Not Recruiting | A Study Following Women in Menopause Treated With a Non-hormonal Therapy for Hot Flashes and Night Sweats Hot Flashes | — | 2023-11-15 |
| Completed | A Study to Find Out if ASP5354 Can Clearly Help Show the Ureter During Surgery Intraoperative Ureter Visualization, Abdominolpelvic Surgery | Phase 3 | 2023-08-02 |
| Recruiting | A Study of ASP1002 in Adults for Treatment of Solid Tumors Advanced Solid Tumors | Phase 1 | 2023-03-13 |
| Terminated | A Study of ASP2074 in Adults With Solid Tumors Advanced Solid Tumors | Phase 1 | 2023-02-28 |
| Active Not Recruiting | A Study of Gilteritinib, Venetoclax and Azacitidine as a Combined Treatment for People Newly Diagnosed With Ac Acute Myeloid Leukemia (AML), FLT3-mutated Acute Myeloid Leukemia | Phase 1 / Phase 2 | 2023-01-31 |
| Completed | Incidence and Clinical Burden of Erythropoietin Hyporesponsiveness - a Retrospective Database Analysis Chronic Kidney Disease | — | 2022-11-18 |
| Completed | Avacincaptad Pegol Open-Label Extension for Patients With Geographic Atrophy Geographic Atrophy, Age-Related Macular Degeneration | Phase 3 | 2022-09-26 |
| Completed | A Study About How ASP5354 Affects the Body in Healthy Adults and in Adults Whose Kidneys do Not Work Well Healthy Volunteers, Renal Impairment | Phase 1 | 2022-08-25 |
| Recruiting | A Study of ASP2138 Given by Itself or Given With Other Cancer Treatments in Adults With Stomach Cancer, Gastro Gastric Adenocarcinoma, Gastroesophageal Junction (GEJ) Adenocarcinoma, Pancreatic Adenocarcinoma | Phase 1 | 2022-06-07 |
| Terminated | A Study to Find a Suitable Dose of ASP8731 and Check for Medical Problems at Each Dose in Healthy Adults Healthy Participants | Phase 1 | 2022-03-07 |
| Completed | A Study to Learn How [14C]ASP0367 is Processed by the Body in Healthy Men Healthy Volunteers | Phase 1 | 2022-01-21 |
| Terminated | Study of ASP0739 Alone and With Pembrolizumab in Advanced Solid Tumors With NY-ESO-1 Expression Participants Ovarian Cancer, NSCLC, ESCC | Phase 1 / Phase 2 | 2021-12-23 |
| Completed | A Study of ASP0367 in People With Kidneys That do Not Work Well and in Healthy People Renal Impairment, Healthy Volunteers | Phase 1 | 2021-12-21 |
| Terminated | A Study of Intravesical Enfortumab Vedotin For Treatment of Patients With Non-muscle Invasive Bladder Cancer ( Urinary Bladder Neoplasms, Carcinoma in Situ, Carcinoma Transitional Cell | Phase 1 | 2021-12-07 |
| Completed | Study of ASP7517 Alone and With Pembrolizumab in Participants With Advanced Solid Tumors Expressing WT1 Antige Advanced Malignancies, Advanced Cancer | Phase 1 / Phase 2 | 2021-11-11 |
| Withdrawn | A Study to Assess the Safety and Efficacy of ASP8062 as an Add-on Therapy to Buprenorphine/Naloxone in Partici Opioid Use Disorder | Phase 2 | 2021-11-08 |
| Completed | A Study of Fezolinetant to Treat Hot Flashes in Women Going Through Menopause Vasomotor Symptoms | Phase 3 | 2021-11-08 |
| Active Not Recruiting | A Study of ASP1570 Taken by Itself, or ASP1570 Taken Together With Either Pembrolizumab, Standard Therapies, o Advanced Solid Tumors | Phase 1 / Phase 2 | 2021-10-19 |
| Completed | A Study to Evaluate ASP0367 in Participants With Mild/Moderate Hepatic Impairment Compared to Participants Wit Hepatic Impairment, Healthy Volunteers | Phase 1 | 2021-09-13 |
| Completed | Survey Based Discrete Choice Experiment Study in Prostate Cancer (DECIDER) Study Prostate Cancer, Metastatic Hormone-sensitive Prostate Cancer | — | 2021-09-03 |
| Terminated | A Study to Evaluate ASP0367 in Participants With Reduced Maximum Oxygen Uptake Due to Poor Systemic Oxygen Ext Reduced Maximum Oxygen Uptake Due to Poor Systemic Oxygen Extraction | Phase 1 | 2021-06-14 |
| Recruiting | A Safety and Dose-finding Study of PRL-02 Depot in Men With Advanced Prostate Cancer Prostate Cancer, Metastatic Castration Resistant Prostate Cancer, Metastatic Castration-sensitive Prostate Cancer | Phase 1 | 2021-06-14 |
| Terminated | A Study to Evaluate Mirabegron in Pediatric Participants From 5 to Less Than 18 Years of Age With Overactive B Overactive Bladder (OAB), Pharmacokinetics of Mirabegron | Phase 3 | 2021-03-15 |
| Completed | A Study to Investigate the Effect of Severe Renal Impairment on Gilteritinib Compared to Healthy Participants Renal Impaired, Gilteritinib, Normal Renal Function | Phase 1 | 2021-01-28 |
| Completed | A Study to Assess the Effect of Food With Fezolinetant in Healthy Female Participants Healthy Subjects | Phase 1 | 2020-11-20 |
| Terminated | A Study to Assess ASP0598 Otic Solution Following Topical Application in the Ear in Subjects With Chronic Tymp Chronic Tympanic Membrane Perforation | Phase 1 / Phase 2 | 2020-09-10 |
| Active Not Recruiting | A Study to Assess the Safety, Tolerability and Immunological Response of ASP2390 in Adult Subjects Allergic to Allergic to House Dust Mites | Phase 1 | 2020-09-09 |
| Terminated | A Study of Gilteritinib (ASP2215) Combined With Chemotherapy in Children, Adolescents and Young Adults With FM Acute Myeloid Leukemia (AML), Acute Myeloid Leukemia With FMS-like Tyrosine Kinase 3 (FLT3) Mutation / Internal Tandem Duplication (ITD) | Phase 1 / Phase 2 | 2020-09-04 |
| Completed | A Study to Investigate the Effect of Mild and Moderate Hepatic Impairment on the Safety and Tolerability of Fe Hepatic Impairment, Healthy Volunteers | Phase 1 | 2020-09-02 |
| Completed | A Study to Investigate the Effect of Renal Impairment on the Safety and Tolerability of Fezolinetant Compared Healthy Volunteers, Renal Impairment | Phase 1 | 2020-08-10 |
| Completed | A Study to Assess the Safety, Tolerability and Pharmacokinetics of Multiple Doses of ASP8062 With a Single Dos Opioid Use Disorder | Phase 1 | 2020-06-30 |
| Completed | A Study to Assess the Effect of a Single Dose of ASP8062 on the Multiple Dose Safety, Tolerability and Pharmac Opioid Use Disorder | Phase 1 | 2020-06-29 |
| Active Not Recruiting | Enfortumab Vedotin and Pembrolizumab vs. Chemotherapy Alone in Untreated Locally Advanced or Metastatic Urothe Urothelial Cancer | Phase 3 | 2020-03-30 |
| Active Not Recruiting | A Study to Evaluate Enfortumab Vedotin in Subjects With Locally Advanced or Metastatic Malignant Solid Tumors Locally Advanced or Metastatic Malignant Solid Tumors | Phase 2 | 2020-03-10 |
| Completed | A Study to Assess Bioequivalence of Fezolinetant Formulations in Healthy Female Participants Healthy Volunteers | Phase 1 | 2020-02-20 |
| Completed | A Study to Evaluate the Effect of Multiple Doses of Enzalutamide on the Pharmacokinetics of Substrates of P-gl Prostate Cancer | Phase 1 | 2020-01-27 |
| Completed | A Study to Assess Isavuconazole Following a Single Dose of Isavuconazonium Sulfate Intravenous Solution Via Na Healthy Subjects | Phase 1 | 2019-09-24 |
| Completed | Study to Assess the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of ASP1617 in Healthy Adult No Healthy Volunteers | Phase 1 | 2019-09-19 |
| Completed | A Study Investigating the Safety, Tolerability and Efficacy of ASP7517 in Subjects With Relapsed/Refractory Ac Acute Myeloid Leukemia (AML), Myelodysplastic Syndrome | Phase 1 / Phase 2 | 2019-09-19 |
| Completed | A Study of an Intratumoral Oncolytic Virus in Patients With Advanced Metastatic Solid Tumors Metastatic Cancer, Solid Tumors, Advanced Cancer | Phase 1 | 2019-09-03 |
| Completed | A Study to Evaluate Isavuconazonium Sulfate for the Treatment of Invasive Aspergillosis (IA) or Invasive Mucor Invasive Mucormycosis, Invasive Aspergillosis | Phase 2 | 2019-08-22 |
| Completed | A Study to Assess the Relative Bioavailability of Roxadustat Following a Single Dose of Pediatric Azo Dye-free Healthy Adult Subjects | Phase 1 | 2019-07-31 |
| Completed | A Study to Assess Potential Interaction Between ASP8062 and Alcohol in Healthy Adult Subjects Healthy Volunteers | Phase 1 | 2019-07-16 |
| Completed | A Study to Find Out if Fezolinetant Helps Reduce Moderate to Severe Hot Flashes in Women Going Through Menopau Hot Flashes | Phase 3 | 2019-07-11 |
| Completed | A Study to Find Out if Fezolinetant Helps Reduce Moderate to Severe Hot Flashes in Women Going Through Menopau Hot Flashes | Phase 3 | 2019-07-10 |
| Completed | A Study to Find Out How Safe Long-term Treatment With Fezolinetant is in Women With Hot Flashes Going Through Hot Flashes | Phase 3 | 2019-07-10 |
| Withdrawn | A Study to Assess ASP2713 in Healthy Subjects Healthy Volunteers | Phase 1 | 2019-07-01 |
| Completed | A Study of ASP2215 (Gilteritinib) Combined With Atezolizumab in Patients With Relapsed or Treatment Refractory Acute Myeloid Leukemia (AML), Acute Myeloid Leukemia With FMS-like Tyrosine Kinase (FLT3) Mutation | Phase 1 / Phase 2 | 2019-06-19 |
| Completed | A Study to Assess the Relative Bioavailability of Gilteritinib Following a Single Dose of Gilteritinib Mini-ta Healthy Volunteer | Phase 1 | 2019-05-21 |
| Completed | A Study to Assess the Safety and Efficacy of ASP1650, a Monoclonal Antibody Targeting Claudin 6 (CLDN6), in Ma Incurable Platinum Refractory Germ Cell Tumors, Tumors | Phase 2 | 2019-03-19 |
| Active Not Recruiting | A Study of Zolbetuximab (IMAB362) in Adults With Pancreatic Cancer Pancreatic Cancer, Metastatic Pancreatic Cancer, Metastatic Pancreatic Adenocarcinoma | Phase 2 | 2019-03-15 |
| Completed | A Study to Evaluate Safety, Tolerability and Immune Response in Adolescents Allergic to Peanut After Receiving Peanut Allergy | Phase 1 | 2019-03-12 |
| Terminated | A Study of ASP1951 in Subjects With Advanced Solid Tumors Advanced Solid Tumors | Phase 1 | 2019-01-14 |
| Active Not Recruiting | A Study of Zolbetuximab (IMAB362) Plus CAPOX Compared With Placebo Plus CAPOX as First-line Treatment of Subje Locally Advanced Unresectable Gastroesophageal Junction (GEJ) Adenocarcinoma or Cancer, Locally Advanced Unresectable Gastric Adenocarcinoma or Cancer, Metastatic Gastric Adenocarcinoma or Cancer | Phase 3 | 2018-11-28 |
| Completed | A Study in Healthy Adult Volunteers to Assess the Safety and Pharmacokinetics of an Investigational Imaging Pr Healthy Subjects | Phase 1 | 2018-10-25 |
| Completed | A Study to Assess the Safety and Efficacy of ASP4345 as Add-on Treatment for Cognitive Impairment in Subjects Schizophrenia | Phase 2 | 2018-07-13 |
| Completed | A Study of ASP1948, Targeting an Immune Modulatory Receptor as a Single Agent and in Combination With a PD-l I Advanced Solid Tumors | Phase 1 | 2018-07-02 |
| Active Not Recruiting | A Study of Zolbetuximab (IMAB362) in Adults With Gastric Cancer Pharmacokinetics of Zolbetuximab, Gastric Cancer, Gastro-esophageal Junction (GEJ) Cancer | Phase 2 | 2018-06-29 |
| Completed | A Study to Evaluate Enfortumab Vedotin Versus (vs) Chemotherapy in Subjects With Previously Treated Locally Ad Ureteral Cancer, Urothelial Cancer, Bladder Cancer | Phase 3 | 2018-06-27 |
| Active Not Recruiting | A Study to Compare Zolbetuximab (IMAB362) and Chemotherapy With Placebo and Chemotherapy in Adults With Gastri Locally Advanced Unresectable Gastroesophageal Junction (GEJ) Adenocarcinoma or Cancer, Locally Advanced Unresectable Gastric Adenocarcinoma or Cancer, Metastatic Gastric Adenocarcinoma or Cancer | Phase 3 | 2018-06-21 |
| Completed | A Study to Assess the Safety, Tolerability, Pharmacodynamics and Pharmacokinetics of ASP6981 in Subjects With Schizophrenia | Phase 1 | 2018-01-22 |
| Completed | Zimura Compared to Sham in Patients With Autosomal Recessive Stargardt Disease (STGD1) Stargardt's Macular Dystrophy | Phase 2 | 2018-01-12 |
| Terminated | A Study of Enfortumab Vedotin Alone or With Other Therapies for Treatment of Urothelial Cancer Carcinoma, Transitional Cell, Urinary Bladder Neoplasms, Urologic Neoplasms | Phase 1 / Phase 2 | 2017-10-11 |
| Completed | A Study of Intravenous and Oral Isavuconazonium Sulfate in Pediatric Patients Hematological Malignancy | Phase 1 | 2017-10-02 |
| Completed | A Multiple-dose Study of ASP8374, an Immune Checkpoint Inhibitor, as a Single Agent and in Combination With Pe Advanced Solid Tumors | Phase 1 | 2017-09-08 |
| Completed | A Trial of the FMS-like Tyrosine Kinase 3 (FLT3) Inhibitor Gilteritinib Administered as Maintenance Therapy Fo Acute Myeloid Leukemia | Phase 3 | 2017-08-16 |
| Completed | A Dose-ranging Study of the Efficacy of ESN364 in Postmenopausal Women Suffering Vasomotor Symptoms (Hot Flash Menopause, Hot Flashes | Phase 2 | 2017-07-19 |
| Completed | A Study to Assess the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of MA-0211 in Healthy Adult Healthy Volunteers | Phase 1 | 2017-06-29 |
| Terminated | A Study to Assess the Anti-fatigability Effect of CK-2127107 in Elderly Male and Female Subjects With Limitati Mobility Limitation | Phase 1 | 2017-06-28 |
| Completed | Study to Assess the Efficacy and Safety of Bleselumab in Preventing the Recurrence of Focal Segmental Glomerul Kidney Transplantation, Primary Focal Segmental Glomerulosclerosis (FSGS) | Phase 2 | 2017-05-22 |
| Completed | A Study to Assess the Analgesic Efficacy and Safety of ASP8062 in Subjects With Fibromyalgia Fibromyalgia | Phase 2 | 2017-05-08 |
| Terminated | A Study of ASP8273 in Subjects With Non-small Cell Lung Cancer (NSCLC) Harboring Epidermal Growth Factor Recep Non-small Cell Lung Cancer (NSCLC), Epidermal Growth Factor Receptor (EGFR) Mutations | Phase 1 | 2017-03-24 |
| Completed | A Study to Assess the Analgesic Efficacy and Safety of ASP0819 in Patients With Fibromyalgia Fibromyalgia | Phase 2 | 2017-03-20 |
| Completed | Registry of Patients Treated With Systemic Mold-Active Triazoles Invasive Fungal Infection | — | 2017-03-16 |
| Withdrawn | A Study for Subjects Who Are Participating in an Astellas-sponsored ASP8273 Study Subjects With NSCLC With an EGFR Activating Mutation | Phase 2 | 2017-02-28 |
| Completed | A Study of ASP2215 (Gilteritinib), Administered as Maintenance Therapy Following Induction/Consolidation Thera Acute Myeloid Leukemia (AML), Acute Myeloid Leukemia With FMS-like Tyrosine Kinase (FLT3) / Internal Tandem Duplication (ITD) Mutation | Phase 2 | 2017-01-10 |
| Recruiting | A Study for Subjects With Prostate Cancer Who Previously Participated in an Enzalutamide Clinical Study Prostate Cancer | Phase 2 | 2016-12-22 |
| Completed | A Study to Evaluate Safety, Tolerability and Immune Response in Adults Allergic to Peanut After Receiving Intr Peanut Allergy | Phase 1 | 2016-12-13 |
| Withdrawn | A Study to Investigate the Absorption, Metabolism and Excretion of [14C]ASP8273 in Subjects With Solid Tumors Epidermal Growth Factor Receptor (EGFR) Mutations, Solid Tumors | Phase 1 | 2016-11-15 |
| Terminated | A Study to Evaluate Escalating Doses of ASP1235 (AGS62P1) Given as Monotherapy in Subjects With Acute Myeloid Acute Myeloid Leukemia | Phase 1 | 2016-11-10 |
| Completed | To Compare the Effects of Immediate-release Tacrolimus and Astagraf XL on Donor-Specific Antibody (DSA) Format Kidney Transplantation | Phase 4 | 2016-09-09 |
| Completed | A Study of ASP2215 (Gilteritinib) by Itself, ASP2215 Combined With Azacitidine or Azacitidine by Itself to Tre Acute Myeloid Leukemia (AML), Acute Myeloid Leukemia With FMS-like Tyrosine Kinase (FLT3) Mutation | Phase 3 | 2016-08-01 |
| Completed | A Study to Evaluate the Pharmacokinetics of ASP1707 and Methotrexate in Patients With Rheumatoid Arthritis Rheumatoid Arthritis | Phase 1 | 2016-07-25 |
| Completed | A Study to Assess the Effect of CK-2127107 on Physical Function in Subjects With Chronic Obstructive Pulmonary Chronic Obstructive Pulmonary Disease (COPD) | Phase 2 | 2016-06-30 |
| Completed | A Study to Evaluate the Efficacy, Safety, and Tolerability of Mirabegron in Men With OAB Symptoms While Taking Benign Prostatic Hyperplasia, Overactive Bladder | Phase 4 | 2016-06-13 |
| Completed | A Randomized Study of Enzalutamide in Patients With Localized Prostate Cancer Undergoing Active Surveillance Prostate Cancer | Phase 2 | 2016-06-09 |
| Completed | A Study of AGS-16C3F vs. Axitinib in Metastatic Renal Cell Carcinoma Metastatic Renal Cell Carcinoma | Phase 2 | 2016-05-03 |
| Completed | Rollover Study for Subjects Who Have Participated in an Astellas Sponsored ASP2215 Trial Advanced Solid Tumors, Acute Myeloid Leukemia | Phase 1 / Phase 2 | 2016-05-03 |
| Terminated | A Study to Evaluate Safety, Tolerability, and Pharmacokinetics of Escalating Doses of AGS67E Given as Monother Acute Myeloid Leukemia | Phase 1 | 2016-03-29 |
| Completed | A Study to Assess Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of ASP4345 in Patients With Schi Schizophrenia | Phase 1 | 2016-03-28 |
| Completed | A Study of Enzalutamide Plus Androgen Deprivation Therapy (ADT) Versus Placebo Plus ADT in Patients With Metas Metastatic Hormone Sensitive Prostate Cancer | Phase 3 | 2016-03-09 |
| Completed | Study to Investigate the Absorption, Metabolism and Excretion of [14C] ASP2215 in Patients With Advanced Solid Advanced Solid Tumors, Pharmacokinetics of 14C-labeled Gilteritinib | Phase 1 | 2016-03-04 |
| Completed | A Study to Assess the Safety, Tolerability, and Pharmacokinetics of ASP5094 Following Multiple Intravenous Dos Rheumatoid Arthritis (RA) | Phase 1 | 2016-02-23 |
| Terminated | A Study of ASP8273 vs. Erlotinib or Gefitinib in First-line Treatment of Patients With Stage IIIB/IV Non-small Non-small Cell Lung Cancer (NSCLC) | Phase 3 | 2016-02-11 |
| Completed | A Study to Assess the Efficacy and Safety of Enzalutamide in Subjects With Advanced Hepatocellular Carcinoma Advanced Hepatocellular Carcinoma | Phase 2 | 2015-11-09 |
| Terminated | A Study of Enzalutamide Re-treatment in Metastatic Castration-resistant Prostate Cancer After Docetaxel and/or Metastatic Castration Resistant Prostate Cancer | Phase 4 | 2015-10-28 |
| Completed | A Study to Investigate the Effect of Hepatic Impairment on the Pharmacokinetics, Safety and Tolerability of AS Hepatic Impairment, Healthy | Phase 1 | 2015-10-23 |
| Completed | A Study of ASP2215 Versus Salvage Chemotherapy in Patients With Relapsed or Refractory Acute Myeloid Leukemia Leukemia, Acute Myeloid (AML) | Phase 3 | 2015-10-20 |
| Terminated | A Study of ASP2215 in Combination With Erlotinib in Subjects With Epidermal Growth Factor Receptor (EGFR) Acti Non-Small-Cell Lung Cancer | Phase 1 / Phase 2 | 2015-09-08 |
| Completed | Determination of Levels of Micafungin in Neonates Suffering From Systemic Candidiasis and/or Candida Meningiti Candidiasis, Systemic, Candida Meningitis | Phase 2 | 2015-05-30 |
| Terminated | Study to Assess Analgesic Efficacy and Safety of ASP3662 in Subjects With Painful Diabetic Peripheral Neuropat Painful Diabetic Peripheral Neuropathy (PDPN) | Phase 2 | 2015-05-27 |
| Completed | Observational Cohort Study of Patients With Castration-Resistant Prostate Cancer (CRPC) Prostate Cancer, Castration-resistant Prostate Cancer, Metastatic Prostate Cancer | — | 2015-03-27 |
| Completed | A Dose Escalation and Expansion Study of ASP4132 to Subjects With Advanced Refractory Tumors and Lymphoma Lymphoma, Refractory Solid Tumors, Advanced Cancer | Phase 1 | 2015-03-23 |
| Completed | A Study of ASP2215 in Combination With Induction and Consolidation Chemotherapy in Patients With Newly Diagnos Acute Myeloid Leukemia | Phase 1 | 2015-01-07 |
| Completed | A Study to Evaluate Safety, Tolerability, and Pharmacokinetics of Escalating Doses of AGS67E Given as Monother Relapsed Lymphoid Malignancy, Refractory Lymphoid Malignancy | Phase 1 | 2014-10-14 |
| Completed | Study to Evaluate the Efficacy, Safety, and Tolerability of Mirabegron in Older Adult Subjects With Overactive Overactive Bladder (OAB) | Phase 4 | 2014-10-07 |
| Completed | A Study to Assess the Efficacy and Safety of Enzalutamide With Trastuzumab in Patients With Human Epidermal Gr HER2 Amplified, Advanced Breast Cancer, Human Epidermal Growth Factor Receptor 2 (HER2) | Phase 2 | 2014-09-05 |
| Completed | A Study to Evaluate Tolerability and Participants Preference Between Mirabegron and Tolterodine Extended Relea Overactive Bladder (OAB) | Phase 4 | 2014-07-24 |
| Completed | Treatment Patterns and Key Healthcare Resource Use in Acute Myeloid Leukemia (AML) With or Without FMS-like Ty Acute Myeloid Leukemia (AML) | — | 2014-06-02 |
| Completed | A Study of Escalating Doses of ASG-22CE Given as Monotherapy in Subjects With Metastatic Urothelial Cancer and Metastatic Urothelial Cancer and Other Malignant Solid Tumors | Phase 1 | 2014-05-14 |
| Completed | A Rollover Study for Subjects That Have Participated in an Astellas Sponsored Linsitinib Trial Advanced Solid Tumors | Phase 2 | 2014-04-16 |
| Completed | A Dose Escalation Study of ASP8273 in Subjects With Non-Small-Cell Lung Cancer (NSCLC) Who Have Epidermal Grow Non-Small-Cell Lung Cancer (NSCLC), Epidermal Growth Factor Receptor Mutations | Phase 1 | 2014-04-09 |
| Completed | A Positron Emission Tomography Occupancy Study Using Ligand [11C]AS2471907 and Following Oral Dosing of ASP366 Pharmacokinetics of ASP3662, Displacement of Radiotracer, Healthy Volunteers | Phase 1 | 2014-04-01 |
| Completed | A Study to Assess the Safety, Tolerability and Pharmacokinetics of ASP015K in Healthy Subjects Healthy Volunteers, Pharmacokinetics of ASP015K | Phase 1 | 2014-03-01 |
| Completed | A Study to Evaluate the Effect of Multiple Doses of Esomeprazole on the Pharmacokinetics of Isavuconazole Pharmacokinetics of Isavuconazole, Healthy Subjects | Phase 1 | 2014-01-01 |
| Completed | A Study to Evaluate the Effect of Multiple Doses of Isavuconazole on the Pharmacokinetics of Repaglinide and C Pharmacokinetics of Repaglinide, Pharmacokinetics of Caffeine, Healthy Subjects | Phase 1 | 2014-01-01 |
| Completed | A Study to Describe Patterns of Care and Outcomes of Men Who Are at High Risk After Experiencing Biochemical F Prostate Cancer, Castration-resistant Prostate Cancer, Metastatic Prostate Cancer | — | 2013-12-31 |
| Completed | An Evaluation of a Cytomegalovirus (CMV) Vaccine (ASP0113) in CMV-Seropositive and CMV-Seronegative Healthy Su Dialysis, Healthy Subjects, Cytomegalovirus Infection | Phase 1 | 2013-12-30 |
| Completed | A Study to Evaluate the Efficacy and Safety of a Vaccine, ASP0113, in Cytomegalovirus (CMV)-Seronegative Kidne Kidney Transplantation Cytomegalovirus (CMV) Negative Recipients | Phase 2 | 2013-11-20 |
| Completed | ASG-15ME is a Study of Escalating Doses of AGS15E Given as Monotherapy in Subjects With Metastatic Urothelial Metastatic Urothelial Cancer | Phase 1 | 2013-11-14 |
| Completed | Dose Escalation Study Investigating the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics of ASP2215 in Acute Myeloid Leukemia | Phase 1 / Phase 2 | 2013-10-09 |
| Completed | A Study to Evaluate the Effect of Verapamil on the Pharmacokinetics of ASP015K in Healthy Adult Subjects Healthy Subjects, Pharmacokinetics of ASP015K | Phase 1 | 2013-10-01 |
| Completed | A Study to Evaluate the Potential Increased Risk of Seizures Among Metastatic Castration-Resistant Prostate Ca Metastatic Castration-resistant Prostate Cancer (mCRPC) | Phase 4 | 2013-09-25 |
| Completed | A Study to Evaluate a Therapeutic Vaccine, ASP0113, in Cytomegalovirus (CMV)-Seropositive Recipients Undergoin Cytomegalovirus (CMV)-Positive Recipients, Allogeneic, Hematopoietic Cell Transplant (HCT) | Phase 3 | 2013-09-11 |
| Completed | Drug-Drug Interaction Study Evaluating Effects of ASP015K on Rosuvastatin Healthy Subjects, Pharmacokinetics of ASP015K | Phase 1 | 2013-05-01 |
| Completed | Repeat Dose Tolerance Study of Regadenoson in Healthy Subjects Healthy Volunteers | Phase 1 | 2013-05-01 |
| Completed | A Study to Assess the Relative Bioavailability Between Two ASP015K Tablets and the Food Effect of a New Tablet Bioavailability of ASP015K, Healthy Subjects, Pharmacokinetics of ASP015K | Phase 1 | 2013-05-01 |
| Completed | A Study to Evaluate the Pharmacokinetics of BAL8728 After a Single Dose of Pyridinylmethyl-14C-Labeled Isavuco Pharmacokinetics of 14C-labeled Isavuconazonium Sulfate, Healthy Subjects | Phase 1 | 2013-04-01 |
| Completed | A Study to Assess the Efficacy and Safety of ASKP1240 in de Novo Kidney Transplant Recipients Kidney Transplantation | Phase 2 | 2013-03-05 |
| Completed | A Study to Assess the Safety, Tolerability and Pharmacokinetics of Single and Multiple Ascending Doses of Fida Pharmacokinetics of Fidaxomicin, Healthy Subjects | Phase 1 | 2013-02-01 |
| Completed | A Study to Evaluate the Effect of Multiple Doses of Isavuconazole on the Pharmacokinetics of Metformin Pharmacokinetics of Isavuconazole, Pharmacokinetics of Metformin, Healthy Subjects | Phase 1 | 2013-02-01 |
| Completed | A Study to Evaluate the Effect of Multiple Doses of Isavuconazole on the Pharmacokinetics of Methotrexate Pharmacokinetics of Isavuconazole, Pharmacokinetics of Methotrexate, Pharmacokinetics of 7-hydroxymethotrexate | Phase 1 | 2013-02-01 |
| Terminated | Study to Compare the Efficacy and Safety of Micafungin Versus Conventional Amphotericin B for the Treatment of Candidiasis | Phase 3 | 2013-02-01 |
| Completed | Safety and Activity of IMAB362 in Combination With Zoledronic Acid and Interleukin-2 in CLDN18.2-positive Gast CLDN18.2-positive Gastric Adenocarcinoma, CLDN18.2-positive Adenocarcinoma of the Gastroesophageal Junction, CLDN18.2-positive Adenocarcinoma of Esophagus | Phase 1 | 2012-10-16 |
| Completed | Study to Evaluate the Pharmacokinetics of 14C-labeled Isavuconazole Following a Single Oral Dose of 14C-labele Pharmacokinetics of 14C-labeled Isavuconazole, Healthy Subjects | Phase 1 | 2012-10-01 |
| Completed | A Study to Evaluate the Long-term Safety and Efficacy of ASP015K in Subjects Previously Enrolled in a Phase 2 Arthritis, Rheumatoid | Phase 2 | 2012-09-26 |
| Terminated | A Phase 1, Dose Escalation Study to Assess the Safety and Tolerability of ASP9853 With Either Docetaxel or Pac Pharmacokinetics of ASP9853, Non-hematologic Malignancies | Phase 1 | 2012-08-28 |
| Withdrawn | A Study to Evaluate the Safety and Efficacy of Enzalutamide in Chemotherapy-Naïve, Symptomatic Patients With M Metastatic Castration-Resistant Prostate Cancer | Phase 2 | 2012-08-01 |
| Completed | Drug Interaction Study of Multiple Doses of Isavuconazole and Single Dose of Atorvastatin Pharmacokinetics of Isavuconazole, Pharmacokinetics of Atorvastatin, Healthy Volunteers | Phase 1 | 2012-08-01 |
| Completed | Efficacy and Safety of IMAB362 in Combination With the EOX Regimen for CLDN18.2-positive Gastric Cancer CLDN18.2-positive Adenocarcinoma of the Gastroesophageal Junction, CLDN18.2-positive Adenocarcinoma of Esophagus, CLDN18.2-positive Gastric Adenocarcinoma | Phase 2 | 2012-07-19 |
| Completed | A Study to Determine Safety and Tolerability of Enzalutamide (MDV3100) in Combination With Abiraterone Acetate Metastatic Castration-Resistant Prostate Cancer | Phase 2 | 2012-07-09 |
| Completed | A Study to Evaluate the Safety and Efficacy of ASP015K in Moderate to Severe Rheumatoid Arthritis Arthritis, Rheumatoid | Phase 2 | 2012-06-19 |
| Completed | A Phase I Study to Compare 3 Different Strengths of an Extended Release Formulation of ASP015K to an Immediate Pharmacokinetics of ASP015K, Food Effect, Healthy Volunteers | Phase 1 | 2012-06-01 |
| Completed | A Study To Evaluate the Pharmacokinetics, Pharmacodynamics, Safety and Tolerability of ASP2408 After Multiple Rheumatoid Arthritis, Pharmacokinetics of ASP2408 | Phase 1 | 2012-06-01 |
| Completed | Drug-drug Interaction Study Between Lopinavir/Ritonavir and Isavuconazole Pharmacokinetics of Isavuconazole, Pharmacokinetics of Lopinavir/Ritonavir, Healthy Volunteers | Phase 1 | 2012-06-01 |
| Completed | A Study to Assess Regadenoson Administration Following an Inadequate Exercise Stress Test as Compared to Regad Coronary Artery Disease (CAD) | Phase 3 | 2012-06-01 |
| Completed | Drug Interaction Study of Multiple Doses of Isavuconazole and a Single Dose of Bupropion Pharmacokinetics of Isavuconazole, Pharmacokinetics of Bupropion, Healthy Volunteers | Phase 1 | 2012-06-01 |
| Completed | Study of the Pharmacokinetics of Isavuconazole in Healthy Non-Elderly and Elderly Male and Female Subjects Pharmacokinetics of Isavuconazole, Healthy Volunteers, Safety and Tolerability in Elderly | Phase 1 | 2012-06-01 |
| Completed | Drug Interaction Study of Isavuconazole and Warfarin in Healthy Male Subjects Pharmacokinetics of Isavuconazole, Pharmacokinetics of S- and R-warfarin, Pharmacodynamics of Warfarin | Phase 1 | 2012-06-01 |
| Completed | Drug Interaction Study of Multiple Doses of Isavuconazole and Single Dose of Dextromethorphan in Healthy Adult Pharmacokinetics of Isavuconazole, Pharmacokinetics of Dextromethorphan, Healthy Adult Volunteers | Phase 1 | 2012-05-01 |
| Completed | Drug Interaction Study of the Effect of Ketoconazole at Steady State on the Pharmacokinetics of a Single Dose Pharmacokinetics of Isavuconazole, Pharmacokinetics of Ketoconazole, Healthy Adult Volunteers | Phase 1 | 2012-05-01 |
| Completed | A Multiple Dose Escalation Study of ASKP1240 in Subjects With Moderate to Severe Plaque Psoriasis Psoriasis | Phase 2 | 2012-04-30 |
| Completed | Drug Interaction Study of Isavuconazole and Methadone Pharmacokinetics of Isavuconazole, Pharmacokinetics of Methadone, Healthy Volunteers | Phase 1 | 2012-04-01 |
| Completed | Drug Interaction Study of Isavuconazole and Oral Contraceptive Containing Ethinyl Estradiol and Norethindrone Pharmacokinetics of Isavuconazole, Pharmacokinetics of Ethinyl Estradiol and Norethindrone, Healthy Volunteers | Phase 1 | 2012-04-01 |
| Completed | A Dose Escalation Study to Assess Safety, Tolerability and Pharmacokinetics of ASP2409 Following a Single Intr Rheumatoid Arthritis, Pharmacokinetics of ASP2409 | Phase 1 | 2012-04-01 |
| Completed | A Study to Look at How a Single Oral Dose of 14C-OSI-906 is Absorbed, Broken Down and Eliminated in the Body Advanced Solid Tumors, Pharmacokinetics of 14C-OSI-906 | Phase 1 | 2012-03-19 |
| Completed | Study of the Effect of Repeat Doses of Isavuconazole on Cardiac Repolarization Pharmacokinetics of Isavuconazole, Healthy Volunteers | Phase 1 | 2012-03-01 |
| Completed | Study of the Effect of Renal Impairment on the Pharmacokinetics of Isavuconazole. Pharmacokinetics of Isavuconazole, Healthy Volunteers, Renal Impaired | Phase 1 | 2012-03-01 |
| Completed | Drug Interaction Study of Isavuconazole and Digoxin Pharmacokinetics of Isavuconazole, Pharmacokinetics of Digoxin, Healthy Volunteers | Phase 1 | 2012-03-01 |
| Completed | A Study to Assess the Effect of Multiple Doses of Isavuconazole on the Pharmacokinetics of a Single Dose of My Healthy Subjects, Pharmacokinetics of Isavuconazole, Pharmacokinetics of Plasma Mycophenolic Acid (MPA) | Phase 1 | 2012-03-01 |
| Completed | A Study to Evaluate the Effect of Multiple Doses of Isavuconazole on the Pharmacokinetics of a Single Dose of Healthy Subjects, Pharmacokinetics of Isavuconazole, Pharmacokinetics of Prednisolone | Phase 1 | 2012-02-01 |
| Completed | Bioavailability of ASKP1240 in Healthy Subjects After Intravenous and Subcutaneous Administration of ASKP1240 Pharmacokinetics of ASKP1240, Pharmacodynamics of ASKP1240, Healthy Volunteers | Phase 1 | 2012-02-01 |
| Completed | A Study to Evaluate the Effect of Multiple Doses of Isavuconazole on the Pharmacokinetics of a Single Dose of Healthy Subjects, Pharmacokinetics of Isavuconazole, Pharmacokinetics of Sirolimus | Phase 1 | 2011-11-01 |
| Completed | A Study to Evaluate a Single Intravenous (IV) Dose Using a New Manufactured Clone and Single Ascending Doses o Pharmacokinetics of ASP2408, Healthy Subjects | Phase 1 | 2011-08-01 |
| Completed | A Dose Escalation Study to Assess the Safety, Tolerability, and Pharmacokinetics of ASP2408 Following Single I Healthy Subjects, Pharmacokinetics of ASP2408 | Phase 1 | 2011-01-01 |
| Completed | A Dose Escalation Study to Assess the Safety, Tolerability, and Pharmacokinetics of ASP4058 Following Single O Pharmacokinetics of ASP4058, Healthy Subjects, Food Effect of ASP4058 | Phase 1 | 2010-08-01 |
| Completed | Study of ASKP1240 After a Single Intravenous Dose at Escalating Dose Levels in Healthy Subjects Pharmacokinetics of ASKP1240, Healthy Volunteers | Phase 1 | 2009-01-01 |
| Completed | Study of the Pharmacokinetics of ASP1941 and the Effect on Glucose Concentrations in Male and Female Young and Healthy Volunteers, Pharmacokinetics of ASP1941 | Phase 1 | 2007-11-01 |
| No Longer Available | Early Access Program (EAP) of Gilteritinib (ASP2215) in Patients With FMS-like Tyrosine Kinase 3 (FLT3) Mutate Acute Myeloid Leukemia (AML), FMS-like Tyrosine Kinase-3 (FLT3) Mutations | — | — |
| Approved For Marketing | Expanded Access Study of Gilteritinib (ASP2215) in Patients With FMS-like Tyrosine Kinase 3 (FLT3) Mutated Rel Acute Myeloid Leukemia (AML), FMS-like Tyrosine Kinase-3 (FLT3) Mutations | — | — |
| Approved For Marketing | Provide Expanded Access to MDV3100 and Monitor Its Safety in Patients With Progressive Castration-Resistant Pr Metastatic Castration-Resistant Prostate Cancer | — | — |
| Approved For Marketing | An Expanded Access Treatment Protocol of Enfortumab Vedotin in Subjects With Locally Advanced or Metastatic Ur Locally Advanced or Metastatic Urothelial Carcinoma (UC) | — | — |
| Available | Early Access Program for Zolbetuximab Locally Advanced Unresectable Gastroesophageal Junction (GEJ) Adenocarcinoma Cancer, Locally Advanced Unresectable Gastric Adenocarcinoma Cancer, Metastatic Gastric Adenocarcinoma Cancer | — | — |